What is the recommended smoking cessation plan, including counseling schedule and first‑line pharmacologic options such as varenicline, bupropion, and nicotine replacement therapy?

Smoking Cessation Plan

All adults who smoke should receive a combination of behavioral counseling (at least 4 sessions totaling 90-300 minutes) plus first-line pharmacotherapy, with varenicline as the preferred medication due to superior efficacy over other options. 1

Behavioral Counseling Framework

The counseling component should include:

• Minimum of 4 in-person sessions with total contact time of 90-300 minutes 1
• Sessions can be delivered by physicians, nurses, psychologists, social workers, or trained cessation counselors 2
• Content should include:
  • Social support provision
  • Training in problem-solving skills (recognizing high-risk situations, developing coping strategies)
  • Development of a specific quit plan
  • Motivational interviewing techniques 2

Alternative delivery methods that are also effective include telephone counseling (minimum 3 calls), individual or group sessions, and mobile phone-based interventions 1, 2. The largest effects are seen with 8 or more sessions, though 4+ sessions show significant benefit 1.

First-Line Pharmacotherapy Options

Varenicline (Preferred Agent)

Varenicline demonstrates the highest cessation rates (25.6% vs 11.1% placebo; RR 2.24) and outperforms both NRT and bupropion in head-to-head comparisons 1, 3, 4.

Dosing schedule 5:

• Days 1-3: 0.5 mg once daily
• Days 4-7: 0.5 mg twice daily
• Day 8 onward: 1 mg twice daily
• Take after eating with full glass of water

Treatment duration:

• Initial 12-week course
• Additional 12 weeks recommended for those who successfully quit (total 24 weeks) to increase long-term abstinence 5

Quit date timing: Start medication 1 week before quit date, OR begin medication and quit between days 8-35 of treatment 5

Dose adjustments:

• Severe renal impairment (CrCl <30 mL/min): 0.5 mg once daily, maximum 0.5 mg twice daily
• End-stage renal disease on hemodialysis: Maximum 0.5 mg once daily 5

Bupropion SR (Second-Line)

Bupropion SR shows good efficacy (19.0% vs 11.0% placebo; RR 1.64) but is less effective than varenicline 1. Consider when varenicline is contraindicated or not tolerated.

Nicotine Replacement Therapy (Alternative)

NRT achieves 16.9% cessation vs 10.5% placebo (RR 1.55) 1. Combination NRT is superior to single-agent NRT - specifically combining a nicotine patch with a rapid-delivery form (gum, lozenge, inhaler, or nasal spray) increases success rates (RR 1.25) 1.

Combination Pharmacotherapy

Combining varenicline with NRT may further improve outcomes beyond varenicline alone, though evidence is still emerging 3, 6. The 2020 American Thoracic Society guideline conditionally recommends combining nicotine patch with varenicline rather than varenicline alone 3.

Combination behavioral counseling plus pharmacotherapy achieves the highest success rates (15.2% vs 8.6% usual care; RR 1.83), significantly better than either intervention alone 1, 4.

Special Populations

Pregnant Persons

• Behavioral counseling is first-line - more intensive counseling with tailored materials about maternal and fetal health effects 1
• Pharmacotherapy evidence is insufficient in pregnancy; behavioral interventions should be maximized 1

Patients with Psychiatric Comorbidity

• Varenicline is safe and effective in patients with psychiatric conditions 3
• Varenicline may actually suppress depressive symptoms during cessation 7
• No increased neuropsychiatric adverse events compared to placebo 5

Common Pitfalls to Avoid

• Don't use pharmacotherapy alone - always combine with behavioral support for maximum efficacy 1, 4
• Don't stop treatment at 12 weeks if successful - extend to 24 weeks total to prevent relapse 5
• Don't avoid varenicline in psychiatric patients - evidence shows it's safe and effective in this population 3
• Don't use single-agent NRT when combination NRT is more effective 1
• Don't give up after one failed attempt - average of 6 quit attempts needed before long-term success 4

Gradual Cessation Approach

For patients unable or unwilling to quit abruptly, varenicline supports gradual reduction:

• Reduce smoking by 50% in first 4 weeks
• Reduce by another 50% in next 4 weeks
• Complete abstinence by week 12
• Continue treatment for additional 12 weeks (24 weeks total) 5